Order

Size
Price
Stock
Qty

MGCD516

 - Sitravatinib
Axon 3998
CAS:  1123837-84-2
Purity:  98%
  • Soluble in DMSO
  • MF:  C33H29F2N5O4S
  • MW:  629.68

Description

MGCD516 is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively. Sitravatinib shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.

More Information

Parent CAS No. 1123837-84-2
Chemical Name N-(3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
extra_info Sold in collaboration with Chemietek
SMILES C1N=C2C=C(C3N=CC(CNCCOC)=CC=3)SC2=C(OC2C=CC(NC(=O)C3(CC3)C(=O)NC3C=CC(F)=CC=3)=CC=2F)C=1
MFCD N.A.
InChi InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
InChiKey WLAVZAAODLTUSW-UHFFFAOYSA-N
CID 25212148
Short Description RTK inhibitor

Related Products

AXON ID NAME FROM PRICE
1251 GW 441756

From $82.50

1394 Imatinib mesylate

From $66.00

1398 Sunitinib malate

From $88.00

1411 Vandetanib

From $55.00

1414 AG 013736

From $55.00

1415 CT 53518

From $77.00

1419 AB 1010

From $77.00

1420 Pazopanib hydrochloride

From $66.00

1461 Cediranib

From $77.00

1547 OSI 930

From $99.00

1610 AZ 23

From $88.00

1637 Vatalanib

From $82.50

1638 ABT 869

From $88.00

1653 AEE 788

From $88.00

1662 CP 547632

From $77.00

1667 SU 5402

From $66.00

1678 Regorafenib

From $77.00

1696 Quizartinib dihydrochloride

From $99.00

1717 Tivozanib

From $88.00

1768 AMG 706

From $115.50

1819 Cabozantinib S-malate

From $66.00

1850 BMS 540215

From $121.00

1864 Brivanib alaninate

From $99.00

1891 SU 6668

From $110.00

Loading...